GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine, covering 2017-01-25 to 2017-01-25. Get the full timeline:
Most recent: Clinical Trial Update: Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years [Phase 2]